Scientific Discoveries

Drug combo may help treat previously resistant tumours

From ANI London, Dec 1: A team of scientists has discovered a potential treatment for a group of tumours that have resisted previous targeted therapy approaches. While conducting a study, researchers from Dana-Farber Cancer...

Smallpox vaccine works a lifetime

BETHESDA, Md., Dec. 1 (UPI) -- Lifetime protection is obtained from just one smallpox vaccination -- even if it occurred 88 years ago, U.S. researchers say. A study, published in The American Journal of Medicine, found that in...

Cell movements totally modular, study shows

A study describing how cells within blood vessel walls move en masse overturns an assumption common in the age of genomics — that the proteins driving cell behavior are doing so much multitasking that it would be near...

Experts seek remedy for health-care waste

Despite huge sums spent, health care in the U.S. remains inefficient and not well managed. By Ceci Connolly The Washington Post WASHINGTON — Talk to the chief executives of America's pre-eminent health-care institutions, and...

New treatment hope for people with recurring depression

Research shows for the first time that a group-based psychological treatment, Mindfulness Based Cognitive Therapy (MBCT), could be a viable alternative to prescription drugs for people suffering from long-term depression.

Study unmasks how ovarian tumors evade immune system

EUREKALERT Contact: David March dmarch1@jhmi.edu Johns Hopkins Medical Institutions Potential exists for drugs to halt shedding of fatty molecules, stop tumor growth and kill cancer Scientists at Johns Hopkins have determined...

FDA Accepts Cell Therapeutics' Zevalin sBLA and Grants Priority Review

SEATTLE, Dec. 1 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing and review, and has granted priority review...

GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America

ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX), an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other...

An about-face on stem cells

New federal grants, less red tape likely with reversal of Bush ban One of Barack Obama's first acts as president is expected to be a reversal of the Bush administration's restrictions on federal funding for research on human...

Nevada Imaging Centers Performs More Than 3,500 Patient Studies Using the World's First Dynamic...

Demonstrating the strength and versatility of the world's first dynamic volume CT system, Nevada Imaging Centers has provided more than 3,500 scans using Toshiba America Medical Systems, Inc.'s Aquilion® ONE dynamic volume CT...